Stay updated with breaking news from Tim Oldham. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AdAlta Ltd (ASX:1AD) CEO Tim Oldham discusses with Proactive the latest developments with its next generation i-body enabled Chimeric Antigen Receptor...
/PRNewswire/ -- Roots Analysis has announced the addition of "Cell Therapy Manufacturing Market (5th Edition), 2022-2035" report to its list of offerings....
The Healthcare industry is a many-faceted beast, consisting of everything from biotech heart valve replacements to oncolytic cancer-fighting viruses and...
AdAlta Ltd (ASX:1AD) says a new publication by its collaborators at University of Western Australia (UWA) and La Trobe University, published in the peer...
AdAlta Ltd (ASX:1AD) has extended the range and diversity of sequences analogous to its lead program AD-214 with the grant of a second patent in Japan by...